Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 3 | Orphanet Journal of Rare Diseases

Figure 3

From: Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis

Figure 3

Positive macro-rheologic impact of cysteamine, N-Acetylcysteine, rhDNase and alginate lyase on mucin. 20% (w/v) porcine stomach mucin was exposed to the 10 mg/ml of the cysteamine and the mucoactive agents listed above for 24 h at 37°C and the viscosity of the samples determined by measuring velocity (distance moved (mm) over time (s)). An equal volume of distilled water (4 μl) was used as a control. The experiment was carried out in triplicate and the bars represent the mean.

Back to article page